Attendance at cervical cancer screening and use of diagnostic and therapeutic procedures on the uterine cervix assessed from individual health insurance data (Belgium, 2002-2006)

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Arbyn, Marc ^a   Fabri, Valérie ^b   Temmerman, Marleen ^c,d   Simoens, Cindy ^a,e  

^a SCIENTIFIC INSTITUTE OF PUBLIC HEALTH   (Belgium)

^b Intermutualistic Agency (IMA/AIM)   (Belgium)

^c GHENT UNIVERSITY   (Belgium)

^d WORLD HEALTH ORGANIZATION   (Switzerland)

^e UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; BELGIUM; CANCER DIAGNOSIS; CANCER SCREENING; CANCER THERAPY; COLPOSCOPY; FEMALE; HEALTH CARE UTILIZATION; HEALTH INSURANCE; HUMAN; HYSTERECTOMY; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; REIMBURSEMENT; UTERINE CERVIX CANCER; UTERINE CERVIX CONIZATION; AGE; BIOPSY; EARLY DIAGNOSIS; INCIDENCE; MIDDLE AGED; PATHOLOGY; SOCIOECONOMICS; UTERINE CERVICAL NEOPLASMS; UTERINE CERVIX;

ADULT; AGE FACTORS; BELGIUM; BIOPSY; CERVIX UTERI; COLPOSCOPY; CONIZATION; EARLY DETECTION OF CANCER; FEMALE; HUMANS; HYSTERECTOMY; INCIDENCE; INSURANCE, HEALTH; MIDDLE AGED; PAPANICOLAOU TEST; SOCIOECONOMIC FACTORS; UTERINE CERVICAL NEOPLASMS;

EID: 84898879341     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0092615     Document Type: Article

References (44)

1. Arbyn M, Castellsagué X, de Sanjosé S, Bruni L, Saraiya M, et al (2011) Worldwide burden of cervical cancer in 2008. Ann Oncol 22: 2675-2686.
2. Arbyn M, Raifu AO, Weiderpass E, Bray F, Anttila A (2009) Trends of cervical cancer mortality in the member states of the European Union. Eur J Cancer 45: 2640-2648.
3. Arbyn M, Geys H (2002) Trend of cervical cancer mortality in Belgium (1954-94): tentative solution for the certification problem of not specified uterine cancer. Int J Cancer 102: 649-654. (Pubitemid 35334475)
4. Arbyn M, Van Oyen H, Sartor F, Tibaldi F, Molenberghs G (2002) Description of the influence of age, period and cohort effects on cervical cancer mortality by loglinear Poisson models (Belgium, 1955-94). Arch Public Health 60: 73-100. (Pubitemid 34823101)
5. IARC (2005) Cervix Cancer Screening. IARC Handbooks of Cancer Prevention. Vol. 10. Lyon: IARCPress. 302 p.
6. Laara E, Day NE, Hakama M (1987) Trends in mortality from cervical cancer in the Nordic countries: association with organised screening programmes. Lancet 1: 1247-1249. (Pubitemid 17070815)
7. Peto J, Gilham C, Fletcher O, Matthews FE (2004) The cervical cancer epidemic that screening has prevented in the UK. Lancet 364: 249-256. (Pubitemid 38942814)
8. Quinn M, Babb P, Jones J (1999) Effect of Screening on Incidence an Mortality from Cancer of the Cercix in England: Evaluation Based on Routinely Collected Statistics. BMJ 318: 904-908. (Pubitemid 29191925)
9. Nygard JF, Skare GB, Thoresen SO (2002) The cervical cancer screening programme in Norway, 1992-2000: changes in Pap smear coverage and incidence of cervical cancer. J Med Screen 9: 86-91. (Pubitemid 34822870)
10. van der Aa MA, Schutter EM, Looijen-Salamon M, Martens JE, Siesling S (2007) Differences in screening history, tumour characteristics and survival between women with screen-detected versus not screen-detected cervical cancer in the east of The Netherlands, 1992-2001. Eur J Obstet Gynecol Reprod Biol 139: 204-209.
11. Arbyn M, Van Oyen H (2000) Cervical cancer screening in Belgium. Eur J Cancer 36: 2191-2197.
12. Arbyn M, Simoens C, Van Oyen H, Foidart J-M, Goffin F, et al. (2009) Analysis of 13 million individual patient records pertaining to Pap smears, colposcopies, biopsies and surgery on the uterine cervix (Belgium, 1996-2000). Prev Med 48: 438-443.
13. Miller AB (2002) The (in)efficiency of cervical screening in Europe. Eur J Cancer 38: 321-326.
14. Coleman D, Day N, Douglas G, Farmery E, Lynge E, et al. (1993) European Guidelines for Quality Assurance in Cervical Cancer Screening. Europe against cancer programme. Eur J Cancer 29A Suppl 4: S1-S38.
15. Council of the European Union (2003) Council Recommendation of 2 December 2003 on Cancer Screening. Off J Eur Union 878: 34-38.
16. European Commission (2008) European Guidelines for Quality Assurance in Cervical Cancer Screening. Luxembourg: Office for Official Publications of the European Communities. 291 p.
17. Anttila A, Ronco G, Lynge E, Fender M, Arbyn M, et al. (2008) Chapter 2: Epidemiological Guidelines for Quality Assurance in Cervical Cancer Screening. In: Arbyn M, Anttila A, Jordan J, Ronco G, Schenck U et al., editors. European Guidelines for Quality Assurance in Cervical Cancer Screening. Luxembourg: Office for Official Publications of the European Communities. pp. 11-52.
18. Arbyn M, Quataert P, Van Hal G, Van Oyen H (1997) Cervical cancer screening in the Flemish Region (Belgium): measurement of the attendance rate by telephone interview. Eur J Cancer Prev 6: 389-398. (Pubitemid 27492125)
19. Demarest S, Drieskens S, Hesse E, Miermans PJ, Tafforeau J, et al. (2006) Health Interview Survey, Belgium, 1997 - 2001 - 2004. 1-50.
20. Caplan LS, McQueen DV, Qualters JR, Leff M, Garrett C, et al. (2003) Validity of women's self-reports of cancer screening test utilization in a managed care population. Cancer Epidemiol Biomarkers Prev 12: 1182-1187. (Pubitemid 37499441)
21. Desai MM, Bruce ML, Desai RA, Druss BG (2001) Validity of self-reported cancer history: a comparison of health interview data and cancer registry records. Am J Epidemiol 153: 299-306. (Pubitemid 32958655)
22. Klungsoyr O, Nygard M, Skare G, Eriksen T, Nygard JF (2009) Validity of self-reported Pap smear history in Norwegian women. J Med Screen 16: 91-97. 16/2/91 [pii]; doi:10.1258/jms.2009.008087.
23. Jordan J, Arbyn M, Martin-Hirsch P, Schenck U, Baldauf J-J, et al. (2008) European guidelines for quality assurance in cervical cancer screening: recommendations for clinical management of abnormal cervical cytology, part 1. Cytopathology 19: 342-354.
24. Weyers S, Crijns P, De Sutter P, Ide P, Orye G, et al. (2005) Opvolging na afwijkende cervixcytologie. Tijdschr voor Geneeskunde 61: 129-134. (Pubitemid 40170511)
25. Arbyn M, Van Nieuwenhuyse A, Bogers J, de Jonge E, Op De Beeck L, et al. (2011) Cytological screening for cervical cancer in the province of Limburg, Belgium. Eur J Cancer Prev 20: 18-24.
26. Tjalma W, Crijns P, De Sutter P, Ide P, Orye G, et al. (2005) Richtlijnen voor de behandeling van vrouwen met abnormaal uitstrijkje. Tijdschr voor Geneeskunde 61: 108-118. (Pubitemid 40170509)
27. Kleinbaum DG, Kupper LL, Morgenstern H (1982) Epidemiologic Research: Principles and Quantitative Methods. New York: Van Nostrand Reinhold. 529 p.
28. Arbyn M, Simoens C, Fabri V (2011) Analysis of individual health insurance data pertaining to pap smears, colposcopies, biopsies and surgery on the uterine cervix (Belgium, 2002-2006). IPH/EPI-REPORTS 2010-021: 1-114.
29. Habbema D, de Kok IM, Brown ML (2012) Cervical cancer screening in the United States and the Netherlands: a tale of two countries. Milbank Q 90: 5-37. doi:10.1111/j.1468-0009.2011.00652.x
30. Arbyn M, Anttila A, Jordan J, Ronco G, Schenck U, et al. (2010) European Guidelines for Quality Assurance in Cervical Cancer Screening. Second Edition - Summary Document. Ann Oncol 21: 448-458.
31. Kyrgiou M, Koliopoulos G, Martin-Hirsch P, Arbyn M, Prendiville W, et al. (2006) Obstetric outcomes after conservative treatment for intra-epithelial or early invasive cervical lesions: a systematic review and meta-analysis of the literature. Lancet 367: 489-498. (Pubitemid 43208905)
32. Arbyn M, Kyrgiou M, Simoens C, Raifu AO, Koliopoulos G, et al. (2008) Perinatal mortality and other severe adverse pregnancy outcomes associated with treatment of cervical intraepithelial neoplasia: a meta-analysis. BMJ 337: a1284.
33. Noehr B, Jensen A, Frederiksen K, Tabor A, Kjaer SK (2009) Depth of cervical cone removed by loop electrosurgical excision procedure and subsequent risk of spontaneous preterm delivery. Obstet Gynecol 114: 1232-1238.
34. Simoens C, Goffin F, Simon P, Barlow P, Antoine J, et al. (2012) Adverse obstetrical outcomes after treatment of precancerous cervical lesions: a Belgian multicentre study. BJOG 119: 1247-1255.
35. Centre for Operational Research in Public Health (2006) Standardized Procedures for Mortality Analysis, version Brussels: Scientific Institute of Public Health.
36. Sirovich BE, Welch HG (2004) Cervical cancer screening among women without a cervix. JAMA 291: 2990-2993. (Pubitemid 38802689)
37. Arbyn M, Wallyn S, Van Oyen H, Nys H, Dhont J, et al. (1999) The new privacy law in Belgium: a legal basis for organised cancer screening. Eur J Health Law 6: 401-407. (Pubitemid 30077105)
38. Onkelinx L, De Clerck S (2010) Wet behoudende diverse bepalingen betreffende gezondheid, hoofdstuk 9, artikel 29. Loi portant des dispositions diverses en matière de santé, chapître 9, article 29. Extension of the Royal Decree on Cancer Registration with respect of cytopathology registration of acts related to early detection of cancer. Belgisch Staatsblad/Moniteur belge 34361.
39. Fruchter RG, Rones K, Roth T, Webber CA, Camilien L, et al. (1992) Pap smear histories in a medical clinic: accuracy of patients' self-reports. N Y State J Med 92: 421-424. (Pubitemid 23058115)
40. Montano DE, Phillips WR (1995) Cancer screening by primary care physicians : a comparison of rates obtained from physician self-report, patient survey, and chart audit. Am J Public Health 85: 795-800.
41. Bowman JA, Sanson-Fisher R, Redman S (1997) The accuracy of self-reported Pap smear utilisation. Soc Sci Med 44: 969-976. S0277953696002225 [pii].
42. Onkelinx L (2009) Arrêté royal modifiant les articles 24 et 32 de l'annexe de l'arrêté royal du 14 septembre 1984 établissant la nomenclature des prestations de santé en matière d'assurance obligatoire soins de santé et indemnités. Koninklijk besluit tot wijziging van de artikelen 24 en 32 van de bijlage van het koninklijk besluit van 14 september 1984 tot vaststelling van de nomenclatuur van de geneeskundige verstrekkingen inzake verplichte verzekering voor geneeskundige verzorging en uitkeringen. Moniteur Belge/Staatsblad 222298: 39264-39266.
43. Onkelinx L (2013) Koninklijk Besluit in verband met terugbetaling van cervixuitstrijkjes. Arrêté royal concernant le remboursement des frottis cervico-vaginaux. Belgisch Staatsblad/Moniteur belge 22088-22089: 11882-11883.
44. Racey CS, Withrow DR, Gesink D (2013) Self-collected HPV Testing Improves Participation in Cervical Cancer Screening: A Systematic Review and Meta-analysis. Can J Public Health 104: e159-e166.